Author Archives: Joana Carvalho

Use of Vertex’s Orkambi and Symdeko To Be Reimbursed in Switzerland

Vertex Pharmaceuticals announced that a reimbursement program covering Orkambi (lumacaftor/ivacaftor) and Symdeko (tezacaftor/ivacaftor combo) will be opening for eligible cystic fibrosis patients (CF) living in Switzerland. The program is part of a recent agreement reached between the company and the Swiss Federal Office of Public Health (FOPH) and…

Trial of Inhaled Treatment for P. aeruginosa Infections Enrolling CF Patients

Enrollment is continuing in a Phase 1/2 trial testing the safety and properties of AR-501, a potential inhalation treatment for chronic lung infections associated with cystic fibrosis (CF), Aridis Pharmaceuticals announced. The company also remains on track during the COVID-19 pandemic to report top-line trial findings: those in healthy volunteers…

Nanoparticles with Plant Sterols May Aid Gene Therapy for CF

Tiny particles, or nanoparticles, work better as transport and delivery vehicles for the RNA molecules central to some forms of gene therapy when plant-based relatives of cholesterol, called phytosterols, are included, scientists report. These findings are in the study, “Naturally-occurring cholesterol analogues in lipid nanoparticles…

Top 10 Cystic Fibrosis Stories of 2019

Cystic Fibrosis News Today brought you daily coverage of important discoveries, treatment developments, clinical trials, and other important events related to cystic fibrosis (CF) throughout 2019. As we look forward to bringing you more CF news this year, we present our 10 most-read stories of 2019. No. 10 –…

Featured Column

Words Between Worlds: Improving Cross-class Communication in Medical Spaces

A banner for Kate Delany's "Breathe and Believe" column that depicts a pair of lungs with flowers blossoming from them.
Columnist Kate Delany investigates how communication between patients, family members, and doctors is often shaped by class origins.

Read the Column

Your CF Community

Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.